DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cipla Share Price Live Updates: Cipla Stock Details

Economic Times 5 hrs ago·2 Sept 2026, 3:05 am

Cipla is a major Indian pharmaceutical company known for producing affordable generic medicines. Investors are closely watching the stock for updates on its performance and strategic direction. The company's ability to maintain its market position in the competitive generic drug sector is a key factor for its future growth.

For investors, the stock's movement reflects broader market sentiment towards the healthcare and pharmaceutical industries. The company's focus on expanding its portfolio and maintaining operational efficiency will be crucial in driving shareholder value. Monitoring its quarterly results and any new product launches will provide insights into its potential.

Moving forward, investors should pay attention to the company's guidance on revenue growth and cost management. Any announcements regarding partnerships or acquisitions could also significantly impact the stock. Keeping an eye on these developments will help in making informed investment decisions.